Effect of cost sharing on prescription drug use by medicare beneficiaries prior to the medicare drug benefit and potential adverse selection in the benefit

Journal of the American Pharmacists Association

Volumn 49, Issue 1, 2009, Pages 18-25

  Goedken, Amber M ^a   Urmie, Julie M ^a   Farris, Karen B ^a   Doucette, William R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adverse selection; Cost sharing; Medicare drug benefit; Older adults; Prescription insurance

Indexed keywords

PRESCRIPTION DRUG;

AGED; ARTICLE; COST; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; ECONOMICS; FEMALE; HEALTH STATUS; HUMAN; INFORMATION PROCESSING; INTERNET; MALE; MEDICARE; SOCIOECONOMICS; STATISTICS; UNITED STATES;

AGED; COST SHARING; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG UTILIZATION; FEMALE; HEALTH STATUS; HUMANS; INTERNET; MALE; MEDICARE PART D; PRESCRIPTION DRUGS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 63849177415     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.08001     Document Type: Article

References (26)

1. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-9.
2. Anis AH, Guh DP, Lacaille D, et al. When patients have to pay a share of drug costs: Effect on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ. 2005;173:1335-40.
3. Li X, Guh D, Lacaille D, et al. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy. 2007;82:340-7.
4. Dormuth CR, Glynn RJ, Neumann P, et al. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther. 2006;28:964-78.
5. Schneeweiss S, Patrick AR, Maclure M, et al. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation. 2007;115:2128-35.
6. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-9.
7. Contoyannis P, Hurley J, Grootendorst P, et al. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada. Health Econ. 2005; 14:909-23.
8. Blais L, Boucher JM, Couture J, et al. Impact of a cost-sharing drug insurance plan on drug utilization among older people. J Am Geriatr Soc. 2001;49:410-4.
9. Pilote L, Beck C, Richard H, Eisenberg MJ. The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients. CMAJ. 2002;167:246-52.
10. Artz MB, Hadsall RS, Schondelmeyer SW. Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons. Am J Public Health. 2002;92:1257-63.
11. Shea DG, Terza JV, Stuart BC, Briesacher B. Estimating the effects of prescription drug coverage for Medicare beneficiaries. Health Serv Res. 2007;42:933-49.
12. Doshi JA, Polsky D. Drug benefit generosity and essential medication use among Medicare-eligible retirees. Am J Manag Care. 2007;13:425-31.
13. Thomas CP, Wallack SS, Lee S, Ritter GA. Impact of health plan design and management on retirees' prescription drug use and spending, 2001. Health Aff (Millwood). 2002;(suppl Web exclusives):W408-19.
14. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care. 1997;35:1119-31.
15. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res. 1997;32:103-22.
16. Balkrishnan R, Byerly WG, Camacho FT, et al. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care. 2001;7:1093-100.
17. Coulson NE, Stuart BC. Insurance choice and the demand for prescription drugs. South Econ J. 1995;61(4):1146-57.
18. Gilman BH, Kautter J. Consumer response to dual incentives under multitiered prescription drug formularies. Am J Manag Care. 2007;13(part 2):353-9.
19. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005;(suppl Web exclusives):W5:152-66.
20. Hoadley J, Hargrave E, Merrell K, et al. Medicare Part D 2008 data spotlight: Benefit design. Menlo Park, CA: Kaiser Family Foundation; 2007.
21. Employer health benefits: 2005 annual survey. Menlo Park, CA: Kaiser Family Foundation/Health Research and Educational Trust; 2005.
22. Prospects for retiree health benefits as Medicare prescription drug coverage begins: findings from the Kaiser/Hewitt 2005 Survey on Retiree Health Benefits. Menlo Park, Calif.: Kaiser Family Foundation/ Hewitt Associates; 2005.
23. Pizer SD, Frakt AB, Feldman R. Predicting risk selection following major changes in Medicare. Health Econ. 2008;17:453-68.
24. Chapter 3: Detailed tables from the Medicare Current Beneficiary Survey data. In: Health and health care of the Medicare population: 2003. Baltimore, MD: Centers for Medicare and Medicaid Services.
25. Koc C. The effects of uncertainty on the demand for health insurance. J Risk Insur. 2004;71:41-61.
26. A detailed description of CBO's cost estimate for the Medicare prescription drug benefit. Washington, DC: Congressional Budget Office; 2004.